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Abstract
Background: A complex interplay between Leishmania and macrophages influences parasite survival and necessitates
disruption of signaling molecules, eventually resulting in impairment of macrophage function. In this study, we
demonstrate the immunomodulatory activity of Berberine chloride in Leishmania infected macrophages.
Principal Findings: The IC50 of Berberine chloride, a quaternary isoquinoline alkaloid was tested in an amastigote
macrophage model and its safety index measured by a cell viability assay. It eliminated intracellular amastigotes, the IC50
being 2.8 fold lower than its IC50 in promastigotes (7.10 mM vs. 2.54 mM) and showed a safety index .16. Levels of
intracellular and extracellular nitric oxide (NO) as measured by flow cytometry and Griess assay respectively showed that
Berberine chloride in Leishmania infected macrophages increased production of NO. Measurement of the mRNA expression
of iNOS, IL-12 and IL-10 by RT-PCR along with levels of IL-12p40 and IL-10 by ELISA showed that in infected macrophages,
Berberine chloride enhanced expression of iNOS and IL-12p40, concomitant with a downregulation of IL-10. The
phosphorylation status of extracellular signal related kinase (ERK1/2) and p38 mitogen activated protein kinase (p38 MAPK)
was studied by western blotting. In infected macrophages, Berberine chloride caused a time dependent activation of p38
MAPK along with deactivation of ERK1/2; addition of a p38 MAPK inhibitor SB203580 inhibited the increased generation of
NO and IL-12p40 by Berberine chloride as also prevented its decrease of IL-10.
Conclusions: Berberine chloride modulated macrophage effector responses via the mitogen activated protein kinase
(MAPK) pathway, highlighting the importance of MAPKs as an antiparasite target.
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Introduction
Leishmaniasis is a potentially lethal, vector-borne protozoal
infection caused by the Leishmania parasite and is endemic in 88
countries (66 in the Old World and 22 in the new world) with an
estimated yearly incidence of 1–1.5 million cases of cutaneous
leishmaniasis and 500,000 cases of visceral leishmaniasis (VL,
http://www.who.int/leishmaniasis/burden/en/). As Leishmania
reside within macrophages, they deviously manipulate the host
innate and acquired immune mechanisms. This ensures their
survival within the hostile environment of macrophages and hinges
on their capability to modulate macrophage effector functions
including production of reactive nitrogen intermediates, RNI [1].
Macrophages can induce host cells to produce cytokines that
promote disease progression via regulation of T helper 1 (Th1) and
T helper 2 (Th2) cells. The Th1 cells by secreting IFN-gamma
enhance macrophage microbicidal activity, thus protecting the
host from intracellular Leishmania pathogens [2]. Conversely, the
parasite for survival cleverly augments the Th2 response, leading
to an increased secretion of IL-4 and IL-10, resulting in
attenuation of host defense mechanisms and Leishmania infection
ensues [3].
To sustain Leishmania infection, a critical factor is induction of
IL-10, which has been shown to be influenced by mitogen
activated protein kinases, MAPKs [4]. It has been proposed that
Leishmania lipophosphoglycans can subvert macrophage function
by activation of the extracellular signal related kinase (ERK 1/2),
leading to enhanced levels of IL-10 along with inhibition of IL-12
[5]. This decrease in IL-12 has been attributed to downregulation
of p38 MAPK which favors parasite survival [4]. Therefore, as
ERK and p38 MAP kinases differentially regulate induction of
macrophage effector molecules and dictate the course of infection,
one is tempted to propose that these kinases could be considered as
potential targets for development of novel strategies to combat
Leishmaniasis.
Berberine chloride [1, 8,13a- tetra-hydro-9, 10- demethoxy-2,
3- (methyl-ene-dioxy) - berberium chloride], a medically important
quaternary isoquinoline alkaloid [6] has been demonstrated to
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induce IL-12 production following activation of p38 MAPK [7].
As its pharmacological spectrum includes anti-leishmanial activity
[8,9,10], this study aimed to establish whether Berberine chloride
induced modulation of the MAPK pathways contributed towards
its anti-leishmanial activity, thereby establishing a new chemo-
therapeutic target against Leishmaniasis.
Methods
Reagents
All chemicals including Berberine chloride were obtained from
Sigma-Aldrich (St. Louis, MO, USA) except N-1 napthyl ethylene
diamine dihydrochloride (Loba Chemie Pvt. Ltd., Mumbai, India),
sulphanilamide, and phenazine methosulphate, PMS (Sisco
Research Laboratories, Mumbai, India), MTS or 3-(4,5-di-
methylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)
-2H-tetrazolium, p38 MAPK inhibitor, SB203580 (Promega,
Madison, Wisconsin, USA), 4,5 diaminofluorescein -2 diacetate
(DAF-2DA, Cayman Chemicals, Ann Arbor, Michigan, USA), 16
well Lab-tek chamber slides, (Nalgen Nunc International,
Rochester, New York USA), RNAqueousH Kit (Ambion, Austin,
Texas, USA), One Step RT-PCR kit from Qiagen (Hilden,
Germany), primers (Sigma Genosys, India), antibodies against
phosphorylated p38 (pp38) MAPK, extracellular signal related
kinase-1/2 (p-ERK), alkaline phosphatase-conjugated anti-mouse
immunoglobin G (Santa Cruz Biotechnology Inc, Santa Cruz,
California, USA), antibody against ERK1/2 (Cell Signalling
Technology, Inc), anti-mouse IL-12, IL-10 along with biotiny-
lated anti-mouse IL-12 and IL-10 (eBioscience, Kensington South
Australia, Australia) and Limulus amebocyte lysate (LAL) assay
kit (Bio Whittaker, Germany).
A 50 mM stock solution of Berberine chloride was prepared in
methanol and stored at 220uC. The presence of bacterial
endotoxin in Berberine chloride was measured by Limulus
amebocyte lysate (LAL) assay as per manufacturer’s instructions.
Briefly, samples were incubated serially with LAL and chromo-
genic substrate; the detection of endotoxin was measured by
generation of p-nitroaniline at 405 nm and quantified against a
standard curve of supplied bacterial endotoxin.
Animals
BALB/c mice of either sex (average wt, 25–30 g) were
maintained at standard temperature (2565uC), a 12 h day/night
cycle, fed a standardized pellet diet and provided water ad libitum.
All experimental protocols received prior approval from the
Institutional Animal Ethical Committee.
Parasite culture
Promastigotes from an Indian Leishmania donovani isolate (NS2)
were routinely passaged in BALB/c mice and after transformation,
cultured at 24uC in Medium 199 supplemented with 10% heat
inactivated fetal calf serum (HIFCS), Penicillin G (50 IU/ml) and
Streptomycin (50 mg/ml). For infection of macrophages, 24 h
prior to the experiment, stationary phase promastigotes were
centrifuged and the pellet resuspended in Schneider’s insect
medium supplemented with 20% HIFCS, pH 5.5 [11].
Ex vivo anti amastigote activity in macrophages
Peritoneal macrophages lavaged from BALB/c mice were
seeded in 16 chamber slides (1.56105/200 ml/well of complete
RPMI-1640, PR2 medium) and after a 2–4 h incubation at 37uC,
5% CO2, the supernatants (containing lymphocytes) were gently
removed and kept aside at 37uC, 5% CO2. Adherent macrophages
were then infected with stationary phase L. donovani promastigotes
(preconditioned at 25uC for 24 h in Schneider’s insect medium,
pH 5.5 [11] at a macrophage: parasite ratio of 1:10 and incubated
for 5 h at 37uC, 5% CO2. After removal of non-internalized
parasites, macrophages were then co-cultured with the above
mentioned supernatants in the presence or absence of Berberine
chloride (0–25 mM) for 72 h, after which cells were fixed, Giemsa
stained (diluted 1:7 in deionized water, pH 6.8) and examined
microscopically for intracellular amastigotes. At least 100 macro-
phages/well were counted to calculate the percentage of infected
macrophages. The infection rate of treated macrophages was
normalized to 100% for further analysis.
Safety index of Berberine chloride
To evaluate the cytotoxicity of Berberine chloride, murine
macrophages (1.56105/200 ml/well) were incubated with Berber-
ine chloride (0–100 mM) at 37uC, 5% CO2 for 48, 72 and 96 h
and cell viability enumerated by the MTS assay [12]. The safety
index was calculated as the IC50 of Berberine chloride in
macrophages/IC50 of Berberine chloride in amastigotes.
Determination of Nitric oxide (NO) in L. donovani infected
macrophages
Intracellular generation of NO was measured in L. donovani
infected macrophages using 4,5 diaminofluorescein-2 diacetate
(DAF-2DA), based on its propensity to enter the cell, release its
diacetate groups following hydrolysis by cytosolic esterases and the
resultant DAF-2 in the presence of NO gets converted into an
impermeable and importantly, highly fluorescent triazolofluor-
escein, DAF-2T [13,14].
Murine peritoneal macrophages (16106/ml of complete RPMI-
1640 PR2 medium) seeded in 6-well plates were infected with
stationary phase L. donovani promastigotes as described above.
Following a 24 or 48 h incubation with an IC50 and IC90
concentration of Berberine chloride (2.5 and 10 mM), adherent
cells were scraped, washed and resuspended in PBS containing
DAF-2DA, 2.0 mM [14,15] for 30 min. at 37uC. The cells were
acquired on a FACS Calibur (Becton Dickinson, USA) in terms of
the geometric mean fluorescence channel (GMFC) of 10,000
macrophages (as defined by forward and side scatter) and analyzed
by BD CellQuest Pro software (BD Biosciences, USA).
Extracellular NO was extrapolated following measurement of
nitrite, a stabilized oxidized product of NO using the Griess assay
[16]. Briefly, murine peritoneal macrophages (16106/ml of
complete RPMI-1640 PR2 medium) were infected with L. donovani
promastigotes as described and then treated with Berberine
chloride (0–10 mM) for 48 h; supernatants were used to measure
NO using the Griess reagent, NED (0.1% in distilled water) and
Sulphanilamide (1% in 5% H3PO4); a standard curve was
generated using NaNO2, 0–100 mM [17].
Reverse transcriptase polymerase chain reaction (RT-PCR)
Total RNA was isolated using the RNAqueousH Kit from
normal and Leishmania infected macrophages (obtained from
BALB/c mice) after being treated with an IC50 and IC90
concentration of Berberine chloride (2.5 and 10 mM) for 18 h.
Subsequently, RT-PCR was carried out with the one-step RT-
PCR kit using RNA (200 ng/reaction) that was reverse-tran-
scribed into cDNA and amplified, using gene-specific primers [18]
for b-actin (Sense: 59-TGGAATCCTGTGGCATCCATGAAA-
C-39, Anti-sense: 59-TAAAACGCAGCTCAGTAACAGTCCG-
39), IL-12p40 (Sense: 59 CAGAAGCTAACCATCTCCTGGT-
TTG-39, Anti-sense: 59-TCCGGAGTAATTTGGTGCTTCA-
CAC), IL-10 (Sense: 59-CTGGAAGACCAAGGTGTCTAC-39
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Anti-sense: 59-GAGCTGCTGCAGGAATGATGA-39) and iNOS
(Sense: 59-CATGGCTTGCCCCTGGAAGTTTCTCTTCAAA-
G-39 Anti-sense: 59-GCAGCATCCCCTCTGATGGTGCCATC-
G-39). For reverse transcription, all samples were subjected to an
initial incubation at 50uC for 30 min followed by an initial PCR
activation (95uC for 15 min) as per the manufacturer’s instructions.
Samples underwent 35 cycles of denaturing (94uC for 30 s),
annealing (58uC for 45 s) and extension (72uC for 30 s). For each
RT-PCR, the mRNA expression was determined in the mid log
phase of the amplification curve after a terminal extension step at
72uC for 10 min. The RT-PCR products were resolved by
electrophoresis on agarose gels (1.5%), containing ethidium
bromide (0.5 mg/ml) and visualized with the Molecular Imager
Chemi Doc XRS System (Bio Rad, California, USA). The
expression of IL-12p40, IL-10 and iNOS and b-actin was quantified
by densitometric analysis using Versa-doc Imaging system (BioRad,
USA), software (Quantity one - 4.6.2 basic).
Measurement of IL-12 and IL-10 by sandwich ELISA
Levels of mouse IL-12p40 and IL-10 present in supernatants of
uninfected and L. donovani infected macrophages that had been treated
with Berberine chloride for 24 h weremeasured using an ELISA kit as
per the manufacturer’s instructions. A standard curve with a cytokine-
positive control was run in each assay, the lower limit of detection
being 15.0 pg/ml for IL-12p40 and 31.25 pg/ml for IL-10.
Western blotting
Peritoneal macrophages isolated from BALB/c mice were
infected with stationary phase promastigotes (1:10) as described
above, following which they were treated with Berberine chloride
(10 mM) for 30 min to 6 h. The adherent cell population was
scraped, centrifuged (400 g615 min, 4uC) and resuspended in ice-
cold extraction buffer containing Tris-HCl (50 mM, pH 7.5),
EGTA (50 mM), b-mercaptoethanol (50 mM) and protease
inhibitors, leupeptin (0.33 mM), phenylmethylsulfonyl fluoride
(0.2 mM), antipain (0.35 mM), chymostatin (0.24 mg/ml), pep-
statin (0.35 mM) and aprotinin (4.8 units/ml). After sonication, the
resultant lysate was centrifuged (4250 g for 10 min at 4uC) and
supernatants collected. Equal amounts of total cellular proteins
(40 mg) were resolved on SDS-polyacrylamide mini gels (SDS-
PAGE 10%) and transferred to nitrocellulose membranes. After
blocking the membranes overnight with blocking buffer (20 mM
Tris-HCl, pH 7.4, 125 mM NaCl and 3% bovine serum albumin),
they were incubated overnight with anti-phosphorylated p38 or
anti- phosphorylated ERK 1/2 (1:500 dilution in 0.5% BSA in
Tris buffered saline, TBS) or total anti ERK1/2 (1:1000 dilution in
0.5% BSA in TBS). Binding was detected using alkaline
phosphatase conjugated anti-rabbit IgG and the immunoreactive
bands were visualized using nitroblue tetrazolium-5-bromo-4-
chloro-3-indolylphosphate, NBT-BCIP [19] which were quanti-
fied densitometrically using the Versa doc Imaging system (Bio
Rad, USA), software (Quantity one - 4.6.2 basic).
Statistical Analysis
Results were expressed as mean 6 SD/SEM as indicated.
Statistical analysis was evaluated by one way ANOVA followed by
Tukey’s Multiple Comparison Test using Graph Pad Prism software,
version 4; p,0.05 was considered as statistically significant.
Results
Anti-amastigote activity of Berberine chloride
During Leishmania infection, promastigotes transform into
amastigotes within phagolysosomal vacuoles of macrophages.
Accordingly, the anti-leishmanial activity of Berberine chloride
(0–25 mM, 72 h) was evaluated in terms of the intracellular
parasite load, wherein the infection rate of Leishmania infected
macrophages was normalized to 100%; with the addition of
Berberine chloride, a dose dependent reduction in parasitic load
was evident, the IC50 being 2.54 mM (Figure 1).
To evaluate the safety index of Berberine chloride, its effect on
the viability of murine macrophages was evaluated by the MTS-
PMS assay. The IC50 of Berberine chloride in macrophages at 48,
72 and 96 h was 44.16, 41.66 and 36.16 mM respectively (Figure 1,
inset) indicating that the IC50 of Berberine chloride in macro-
phages was at least 16 fold higher than its IC50 in amastigotes.
In macrophages, 93% were parasitized and the average number
of amastigotes/macrophage was 11.5. After treatment with
Berberine chloride (72 h), the % of infected macrophages
decreased in a dose dependent manner. With 10 mM Berberine
chloride, only 60% of macrophages were infected, the number of
amastigotes/macrophage being 1.8.
Effect of Berberine chloride on production of NO in
parasitized macrophages
NO is an important biological signaling and effector molecule
necessary for killing intracellular parasites. Leishmania survive and
propagate within host macrophages by inhibiting several macro-
phage functions, including production of RNI. Therefore, it is
anticipated that an anti-leishmanial compound will influence
production of NO. In uninfected macrophages, Berberine chloride
caused no morphological changes as evidenced by an unchanged
forward (FSC) and side scatter (SSC), cells remaining predomi-
nantly in the R1 gate (Figure 2A). However, with parasitization,
morphological changes included enhancement of the internal
granularity of macrophages (Figure 2A); this remained unchanged
with addition of Berberine chloride (Figure 2A).
In uninfected macrophages, an IC50 and IC90 concentration of
Berberine chloride (2.5 and 10 mM, 24 h) induced a 1.24 and 1.52
fold increase in production of NO, the baseline GMFC increasing
from 54.5763.17 to 68.0661.3 and 82.8861.66 respectively
(Figure 2B). However, infection with Leishmania translated into a
significant 1.8 fold decrease in production of NO, as compared
with uninfected macrophages, GMFC being 32.8464.76
(p,0.001, Figure 2B); this was normalized by Berberine chloride
(2.5 and 10 mM) as it caused a significant 1.7 and 2.0 fold increase
(as compared to infected macrophages) to 56.2262.22 (p,0.001)
and 65.7863.22 (p,0.001) respectively (Figure 2B).
At 48 h, basal levels of NO increased in uninfected macro-
phages, GMFC being 79.6563.08, but Berberine chloride caused
no alterations (Figure 2C). Infection with Leishmania again
considerably decreased production of NO as compared with their
uninfected counterparts, GMFC being 24.4261.98 (p,0.001,
Figure 2C); once again, Berberine chloride (2.5 and 10 mM)
increased their generation of NO by 3.2 and 3.5 fold, GMFC
being 79.1166.9 (p,0.001) and 85.5768.33 (p,0.001) respec-
tively (Figure 2C). Methanol, the vehicle control, showed no effect,
thereby confirming its immunological inertness (data not shown).
To corroborate these findings, extracellular NO was concom-
itantly measured; in uninfected macrophages at 24 h, generation
of NO was 4.0860.52 mM, which with Berberine chloride (2.5
and 10 mM) increased marginally to 5.3760.33 and 5.6960.16
respectively (Figure 2D); infection with L. donovani, caused minimal
changes in generation of NO, and remained unchanged in the
presence of Berberine chloride (Figure 2D).
At 48 h, extracellular NO in uninfected macrophages increased
2.1 fold as compared to levels at 24 h (8.6861.16 mM), which was
slightly decreased by Berberine chloride (2.5 and 10 mM) to
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6.4561.50 and 6.1561.29 mM respectively (Figure 2E). Following
infection, a 1.68 fold decrease ensued as compared with uninfected
macrophages (5.1460.77 mM, p,0.01) which was significantly
increased by Berberine chloride (2.5 and 10 mM) to
8.6162.60 mM (p,0.01) and 7.1862.25 mM respectively, attain-
ing levels comparable with uninfected macrophages (Figure 2E).
The LAL assay estimated that the amount of endotoxin in
Berberine chloride was 0.01 IU/ml; therefore the Berberine
chloride-induced production of NO was not an endotoxin-
mediated response.
Berberine chloride enhanced mRNA expression of iNOS
The increased generation of NO is an established event necessary
for elimination of Leishmania parasites and its production hinges
upon activation of iNOS [20,21]. In uninfected macrophages,
Berberine chloride (2.5 and 10 mM) induced a 10 and 17 fold
increase in the mRNA expression of iNOS (Figure 2F). Parasitiza-
tion translated into a down regulation of iNOS which was effectively
reversed by Berberine chloride (2.5 and 10 mM, Figure 2F).
Berberine chloride enhanced mRNA expression of
IL-12p40
Macrophages upon stimulation by Th1 cells secrete several pro-
inflammatory cytokines including IL-1b, IL-6 and IL-12 [22].
Amongst these, IL-12 a heterodimeric cytokine is critical for
development of Th1 cells, as it ensures macrophage activation
[23,24]. In uninfected macrophages (Figure 3A), Berberine
chloride (2.5 and 10 mM) induced an increase in mRNA
expression of IL-12p40 (Figure 3A). Following infection with
Leishmania parasites (as confirmed by Giemsa staining), a down
regulation in mRNA expression of IL-12p40 was observed, which
was reversed by Berberine chloride (Figure 3A).
This genetic upregulation of IL-12p40 by Berberine chloride
was corroborated by quantifying levels in culture supernatants. In
uninfected macrophages, the mean 6 SEM was 474.006
26.94 pg/ml, which with Berberine chloride (2.5 and 10 mM)
significantly increased by 1.88 and 1.93 fold to 895.00628.87
(p,0.001) and 915.00625.98 pg/ml (p,0.001) respectively
(Figure 3B). Following successful intracellular Leishmania infection,
levels of IL-12 reduced significantly by 1.6 fold, mean 6 SEM
being 293.4622.12 pg/ml (p,0.05); importantly, treatment with
Berberine chloride (2.5 and 10 mM) significantly increased
production of IL-12p40 to 505.6662.88 (p,0.05) and
551.2630.86 pg/ml (p,0.01) respectively compared with infected
macrophages (Figure 3B).
Berberine chloride down regulated IL-10 in macrophages
IL-10, a class II a-helical cytokine, has been well documented to
contribute to disease progression in Leishmaniasis by disabling the
Th1 driven responses, deactivating macrophages and thus
ensuring disease progression [19,25,26,27]. In uninfected macro-
phages, Berberine chloride (2.5 and 10 mM) caused minimal
changes in mRNA expression of IL-10 (Figure 4A). Following
parasitization, the 1.4 fold upregulation was effectively decreased
by Berberine chloride (Figure 4A).
In parasitized macrophages, the down regulation of IL-10 by
Berberine chloride was corroborated by quantifying levels in
culture supernatants. In uninfected macrophages, the mean 6
SEM was 148.2612.5 pg/ml and remained unchanged with
Berberine chloride (2.5 and 10 mM, Figure 4B). Following
successful intracellular Leishmania infection, levels of IL-10
increased by 2.64 fold, mean 6 SEM being 392.5612.5 pg/ml.
Importantly, treatment with Berberine chloride (2.5 and 10 mM)
significantly decreased production of IL-10 to 120.5610.5
(p,0.01) and 125.0615.5 pg/ml (p,0.05) respectively as com-
pared with infected macrophages (Figure 4B).
Berberine chloride enhanced phosphorylation of p38
MAPK along with decreased phosphorylation of ERK 1/2
in macrophages
To examine the role of Berberine chloride on the MAPK
pathway in Leishmaniasis, the kinetics of p38 MAPK and ERK 1/
Figure 1. Anti amastigote activity and safety index of Berberine chloride. The anti-leishmanial activity of Berberine chloride (0–25 mM, 72 h)
was tested in intracellular amastigotes as described in Methods. Each point corresponds to the mean 6 SD of at least three experiments in duplicate.
Inset: The effect of Berberine chloride (0–100 mM) on viability of murine macrophages was evaluated at 48 h (&), 72 h (m) and 96 h (.) by the MTS-
PMS assay as described in Methods. Each point corresponds to the mean 6 SD of at least three experiments in duplicate.
doi:10.1371/journal.pone.0018467.g001
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2 phosphorylation were initially studied in uninfected macrophag-
es (30 min–6 h); Berberine chloride did not alter the status of ERK
1/2 and p38 MAPK (Figure 5A). Parasitization by Leishmania as
confirmed by Giemsa staining (data not shown) translated into an
increased phosphorylation of ERK 1/2 (Figure 5B); the addition of
Berberine chloride progressively decreased this activation, maxi-
mally at 2 h and was sustained up to 6 h (Figure 5B). With regard
to p38 MAPK, Leishmania infection resulted in a pronounced
decrease in its phosphorylation (Figure 5B) which was effectively
reversed by Berberine chloride, evident from 2 h onwards
(Figure 5B). Expression of total ERK was studied in both
uninfected and L. donovani infected macrophages; the addition of
Berberine chloride caused no changes in its expression (Figures 5A
and B).
Following L. donovani infection, the phosphorylation of p38
MAPK was down regulated (Figure 5B) which remained
unchanged in the presence of an inhibitor of p38 MAPK
(SB203580, data not shown). To prove that Berberine chloride
mediated anti-leishmanial activity was through activation of p38
MAPK pathways, anti-amastigote activity of Berberine chloride
(0–10 mM, 72 h) was determined following pre-treatment with
SB203580 (10 mM, 1 h). The anti-leishmanial activity was
evaluated in terms of the intracellular parasite load, wherein the
infection rate of Leishmania infected macrophages was normalized
to 100%; addition of SB203580 along with Berberine chloride
raised the IC50 substantially so much so that even with 10 mM
Berberine chloride, the IC50 could not be achieved. This validated
that Berberine chloride mediated up regulation of p38 MAPK
pathway, which was critical for its anti-leishmanial activity.
To confirm whether the enhanced generation of NO by
Berberine chloride (Figure 2) occurred due to activation of the p38
MAPK pathway, L. donovani infected macrophages were pre
treated with SB203580, a p38 MAPK inhibitor (10 mM, 1 h),
followed by Berberine chloride (10 mM, 48 h). At 24 and 48 h,
SB203580 prevented Berberine chloride induced increase in
intracellular NO by 45.27% and 35.64% respectively (data not
shown), as also inhibited Berberine chloride-induced IL-12p40 by
31.95% and 44.37%. Additionally, SB203580 prevented the
Berberine chloride induced decrease in IL-10. However,
SB203580 itself had no effect on levels of NO, IL-12p40 and
IL-10 (data not shown).
Discussion
The remarkable propensity of Leishmania to survive within
macrophages depends on their ability to devise strategies to evade
Figure 2. Effect of Berberine chloride on generation of NO and expression of iNOS. A: A representative dot plot of uninfected (a) and
Leishmania infected (d) murine peritoneal macrophages, that were treated with Berberine chloride (10 mM, 48 h, b, e). Cells were gated on the basis
of characteristic linear forward and side scatter features of macrophages and subsequently DAF-2T fluorescence was measured on a logarithmic scale
in the FL1 channel. A representative histogram of uninfected macrophages (c, --) and L. donovani infected macrophages (f, --) for DAF-2T that were
treated with Berberine chloride (…) macrophages as described in Methods. B: Uninfected macrophages (16106/ml, %, a) or L. donovani infected
macrophages (&, a) were treated for 24 h with Berberine chloride 2.5 mM (b) and 10 mM (c), and processed for measurement of DAF-2T fluorescence
as described in Methods. Data are expressed as the mean GMFC6 SEM of at least 3 experiments in duplicate. C: Uninfected macrophages (16106/ml,
%, a) or L. donovani infected macrophages (&, a) were treated for 48 h with Berberine chloride 2.5 mM (b) and 10 mM (c) and processed for
measurement of DAF-2T fluorescence as described in Methods. Data are expressed as the mean GMFC 6 SEM of at least 3 experiments in duplicate.
D: Uninfected macrophages (16106/ml, %, a) or L. donovani infected macrophages (&, a) were treated for 24 h with Berberine chloride 2.5 mM (b)
and 10 mM (c) and assayed for levels of extracellular NO as described in Methods. Each point represents the mean 6 SEM of NO2
2 (mM) of at least 3
experiments in duplicate. E: Uninfected macrophages (16106/ml, %, a) or L. donovani infected macrophages (&, a) were treated for 48 h with
Berberine chloride 2.5 mM (b) and 10 mM (c) and assayed for levels of extracellular NO as described in Methods. Each point represents the mean 6
SEM of NO2
2 (mM) of at least 3 experiments in duplicate. F: Uninfected macrophages (a) and L. donovani infected macrophages (d) were treated for
18 h with Berberine chloride 2.5 mM (b, e) or 10 mM (c, f). RNA was isolated and subjected to RT-PCR and the products of b-actin and iNOS mRNA were
resolved on an agarose gel (1.5%) and quantified densitometrically using Total lab software as described in Methods.
doi:10.1371/journal.pone.0018467.g002
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or impair host defense mechanisms [1,28]. It is known that the
major anti-leishmanial effector molecule produced by activated
macrophages is NO, essential to kill intracellular amastigotes [29].
Berberine chloride demonstrated potent anti-leishmanial activity
in promastigotes, IC50 being 7.1 mM [10] and as its IC50 decreased
2.8 fold in amastigotes (Figure 1), it suggested that Berberine
chloride besides being directly cytotoxic to parasites also exerted
an immunomodulatory effect upon Leishmania infected macro-
phages. Its high safety index (.16 fold, Figure 1, inset) is an
encouraging aspect and a necessary consideration for antimicro-
bial test compounds.
Several plant derived compounds with proven immunomodu-
latory capability in VL, have consistently demonstrated their
ability to enhance production of NO [20,21]. To establish whether
Berberine chloride demonstrated a pro-oxidant activity as
reported in promastigotes [10], its effect on production of NO
was studied in Leishmania infected macrophages. Infection
translated into morphological alterations that included increased
granularity (Figure 2A) and was accompanied by a pronounced
decrease in both intracellular and extracellular production of NO
that importantly, were effectively reversed by Berberine chloride
(Figures 2B, C and E). This increase in NO by Berberine was less
evident at 24 h (Figure 2D) possibly because changes in
extracellular NO are not evident before 48 h [30]. What is
worthy of note is that following parasite clearance, Berberine
chloride simply restored levels of NO (Figures 2A–E), similar to
Figure 3. Effect of Berberine chloride on IL-12p40 in macrophages. A: Uninfected (a) and L. donovani infected (d) macrophages were treated
for 18 h with Berberine chloride 2.5 mM (b, e) or 10 mM (c, f). RNA was isolated, subjected to RT-PCR and the products of b-actin and IL-12 p40 mRNA
were resolved on an agarose gel (1.5%) and quantified densitometrically using Total lab software as described in Methods. B: Uninfected
macrophages (16106/ml, %, a) or L. donovani infected macrophages (&, a) were treated with Berberine chloride 2.5 mM (b) and 10 mM (c) for 24 h
and assayed for levels of IL-12p40 in culture supernatants by ELISA as described in Methods. Each point represents the mean6 SEM of IL-12p40 (pg/
ml) of at least 3 experiments in duplicate.
doi:10.1371/journal.pone.0018467.g003
Figure 4. Effect of Berberine chloride on IL-10 in macrophages. A: Uninfected (a) and L. donovani infected (d) macrophages were treated for
18 h with Berberine chloride 2.5 mM (b, e) or 10 mM (c, f). RNA was isolated, subjected to RT-PCR and the products of b-actin and IL-10 mRNA were
resolved on an agarose gel (1.5%) and quantified densitometrically using Total lab software as described in Methods. B: Uninfected macrophages
(16106/ml,%, a) or L. donovani infected macrophages (&, a) were treated with Berberine chloride 2.5 mM (b) and 10 mM (c) for 24 h and assayed for
levels of IL-10 in culture supernatants by ELISA as described in Methods. Each point represents the mean 6 SEM of IL-10 (pg/ml) of at least 3
experiments in duplicate.
doi:10.1371/journal.pone.0018467.g004
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that demonstrated by SAG (Chatterjee M, personal communica-
tion) and Artemisinin [30]. This is pertinent, as excessive
activation of macrophages may have long term deleterious effects.
Th1 cytokines can induce iNOS leading to oxidation of L-
arginine and subsequent production of citrulline and NO. As
synthesis of NO correlates with killing of Leishmania parasites [31],
the effect of Berberine chloride on mRNA expression of iNOS was
evaluated. In both uninfected and parasitized macrophages, 18 h
treatment with Berberine chloride increased mRNA expression of
iNOS (Figure 2F) which correlated with increased production of
NO.
IL-12, a heterodimeric cytokine secreted by macrophages and
other antigen presenting cells (APCs) are essential for development
of Th1 cells [32], which in turn produce IFN-c and thereby
activate macrophages. Berberine chloride has been reported to
induce IL-12 production through activation of p38 MAPK [7].
Furthermore, Kim et al., [33] showed that Berberine chloride
mediated induction of IL-12 skewed CD4+ T cells from a Th2
towards a Th1 response, potentially favorable for parasite
elimination. In uninfected macrophages, Berberine chloride as
expected, upregulated expression of IL-12 at the mRNA and
protein level (Figures 3A and B). What was of greater interest to us
was its effect on Leishmania infected macrophages, where it sharply
increased mRNA expression and secretion of IL-12 (Figures 3A
and B), similar to previous reports [20,21,34]. From these
observations, we concluded that Berberine chloride upregulation
of IL-12 contributed towards parasite elimination (Figures 3A and
B).
The exacerbation of VL is strongly associated with increased
levels of IL-10 as it counter regulated secretion of pro
inflammatory cytokines and aided parasite survival [35,36].
Although Berberine chloride showed minimal changes in mRNA
expression of IL-10 in uninfected macrophages, it attenuated
increased mRNA expression and secretion of IL-10 in Leishmania
infected macrophages (Figures 4A and B), thus providing
additional evidence of its effectiveness as an anti-leishmanial
agent, meriting further pharmacological investigations.
Deactivation of macrophage functions by Leishmania parasites
has been linked to its ability to induce differential signaling
components of the mitogen activated protein kinase (MAPK)
cascade, which consists of three subtypes namely ERK, JNK and
p38 MAPK [37]. The MAPK pathways have been identified as
the upstream kinases that induce NF-kB activation through
phosphorylation of its inhibitor IkBa [38], which then rapidly
translocates to the nucleus and activates transcription of multiple
kB dependent genes including iNOS and Th1 cytokines [39].
In Leishmaniasis, the CD40-CD40L signaling has been
proposed to regulate secretion of two counter regulatory cytokines,
IL-12 and IL-10 via the p38 MAPK and ERK pathway, by
skewing the CD40 signaling towards ERK 1/2, which then
induces IL-10; in turn, the increased IL-10 prevents CD40
induced p38 MAPK activation, translating into a reduction in IL-
12 [4,40]. Therefore as the anti-leishmanial activity of Berberine
chloride was accompanied with a decrease in IL-10 and increase
in IL-12, one can extrapolate that it has the ability to up regulate
p38 MAPK (thereby increasing IL-12) along with downregulation
of ERK and thus downregulating IL-10.
Accordingly, we studied the effect of Berberine chloride upon
phosphorylation of ERK 1/2 and p38 MAPK wherein it caused
minimal changes in uninfected macrophages (Figure 5A). How-
ever, In Leishmania infected macrophages, it caused a pronounced
deactivation of ERK 1/2 (Figure 5B) which corroborated with its
ability to decrease IL-10 (Figure 4). Concomitantly, Berberine
chloride activated p38 MAPK in Leishmania infected macrophages
(Figure 5B) which correlated with its propensity to increase IL-12
(Figures 3A and B). To validate that activation of p38 MAPK is
critical for anti-leishmanial activity of Berberine chloride we
evaluated the anti-amastigote acitivity of Berberine chloride in the
presence of SB203580, a selective inhibitor of p38 MAPK;
SB203580 attenuated the cytotoxicity of Berberine chloride and
therefore confirmed the contribution of p38 MAPK in its anti-
leishmanial effect. To confirm that the Berberine chloride induced
production of NO and IL-12 in Leishmania infected macrophages
was mediated by the p38 MAPK pathway, we measured
production of NO and IL-12 in the presence of SB203580; as
decreased NO and IL-12 ensued, it corroborated that p38 MAPK
indeed plays an important role in Berberine chloride mediated
generation of NO and IL-12p40. Furthermore, SB203580
prevented the Berberine chloride mediated decrease in IL-10.
Taken together, our data has established that Berberine chloride
exerts its leishmanicidal activity both directly, by inducing an
oxidative burst in parasites [10] and indirectly, via an increase in
IL-12 through enhanced phosphorylation of p38 MAPK. This was
accompanied by a down regulation of ERK1/2 and IL-10, thus
highlighting the importance of modulation of the MAPK pathways
as a potential target for future anti-leishmanial drug development.
Figure 5. Effect of Berberine chloride on MAPK pathway in macrophages. A: A representative profile of uninfected macrophages was
treated with Berberine chloride (10 mM) for 30 min-6 h. The cells were lysed and subjected to Western blotting with anti-pERK1/2 (a), anti-pp38 MAPK
(b) and anti-ERK1/2 (c) as described in Methods. B: A representative profile of Leishmania infected macrophages were treated with Berberine chloride
(10 mM) for 30 min-6 h. The cells were lysed and subjected to western blotting with anti-pERK1/2 (a), anti-pp38 MAPK (b) and anti-ERK1/2 (c) as
described in Methods.
doi:10.1371/journal.pone.0018467.g005
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